Regeneron Pharmaceuticals $803.48 (-2.49, 0.31%)

NASDAQ
96% success, from Analysis 59* of this Model (*Public)
Summary
LONGBUY: Best moves 23 which gains 1229.85, return on capital invested 1.4%
Date Name (*Public) Description Symbol Type Size Action
Date Value Error Logarithmic Error
Details Best Trend by Hindsight Forecast Profit or Loss
Date (*Public) Symbol Strategy Data Origin Slope Sigma Cor % Moves Sigma Moves Gain % Periods Action
Date UTC Location Action Description Object Severity User Action